1. A new old treatment for lupus nephritis. Issue 10289 (29th May 2021) Authors: Mok, Chi Chiu Journal: Lancet Issue: Volume 397:Issue 10289(2021) Page Start: 2027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aptamer‐Based Screen of Neuropsychiatric Lupus Cerebrospinal Fluid Reveals Potential Biomarkers That Overlap With the Choroid Plexus Transcriptome. Issue 7 (18th May 2022) Authors: Vanarsa, Kamala; Sasidharan, Prashanth; Duran, Valeria; Gokaraju, Sirisha; Nidhi, Malavika; Titus, Anto Sam Crosslee Louis Sam; Soomro, Sanam; Stock, Ariel D.; Der, Evan; Putterman, Chaim; Greenberg, Benjamin; Mok, Chi Chiu; Hanly, John G.; Mohan, Chandra Journal: Arthritis & rheumatology Issue: Volume 74:Issue 7(2022) Page Start: 1223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Axl, Ferritin, Insulin‐Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus. Issue 9 (28th July 2016) Authors: Mok, Chi Chiu; Ding, Hui Hua; Kharboutli, Marwa; Mohan, Chandra Journal: Arthritis care & research Issue: Volume 68:Issue 9(2016:Sep.) Page Start: 1303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Belimumab: the first US FDA approved biological therapy for systemic lupus erythematosus. (August 2011) Authors: Mok, Chi Chiu Journal: International journal of clinical rheumatology Issue: Volume 6:Number 4(2011) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art. (3rd July 2017) Authors: Mok, Chi Chiu Journal: Expert review of clinical immunology Issue: Volume 13:Number 7(2017) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biomarkers for Lupus Nephritis: A Critical Appraisal. (19th April 2010) Authors: Mok, Chi Chiu Other Names: Via Charles Academic Editor. Journal: Journal of biomedicine and biotechnology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Calcineurin inhibitors in systemic lupus erythematosus. Issue 3 (June 2017) Authors: Mok, Chi Chiu Journal: Best practice & research Issue: Volume 31:Issue 3(2017:Jun.) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combination strategies for lupus nephritis: facts and controversies. (4th May 2023) Authors: Mok, Chi Chiu Journal: Expert review of clinical immunology Issue: Volume 19:Number 5(2023) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Current role of rituximab in systemic lupus erythematosus. (19th December 2014) Authors: Mok, Chi Chiu Journal: International journal of rheumatic diseases Issue: Volume 18:Number 2(2015) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. De novo lupus nephritis after SARS-CoV-2 infection. (June 2023) Authors: Mok, Chi Chiu; Chu, Chiu Sum; Tse, Sau Mei Journal: Lupus Issue: Volume 32:Number 7(2023) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗